UMDARZI

What this means for you

Not registered yet, but its 06 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98257358

Mark type

Stylized text

Filed

06 Nov 2023

Published for opposition

25 Mar 2025

Attorney of record

Karen Won

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations, namely, an orally administered protein kinase C (PKC) inhibitor for treating cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for use in oncology for medical treatment purposes; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes

Owner

• Ideaya Biosciences, Inc., South San Francisco, CA, US
• Ideaya Biosciences, Inc., South San Francisco, CA, US

Prosecution history

• 24 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 23 Mar 2026 — SOU EXTENSION 2 GRANTED
• 23 Mar 2026 — SOU EXTENSION 2 FILED
• 23 Mar 2026 — SOU TEAS EXTENSION RECEIVED
• 04 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 04 Nov 2025 — SOU EXTENSION 1 GRANTED
• 04 Nov 2025 — SOU EXTENSION 1 FILED
• 04 Nov 2025 — SOU TEAS EXTENSION RECEIVED
• 20 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 25 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 25 Mar 2025 — PUBLISHED FOR OPPOSITION
• 19 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 03 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 16 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 16 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE